Surrozen's Series A Round

Surrozen raised a round of funding on February 15, 2017. Investors include The Column Group.

Surrozen is a biopharmaceutical company focusing on discovering and developing drugs that promote the repair and regeneration of human tissues.…

Articles about Surrozen's Series A Round: